Poland's Celon Pharma Pursues Innovation With Large Clinical Program Starting Next Year
Executive Summary
Following one of the largest initial public offerings this year in Poland, Celon Pharma is pioneering the development of innovative pharmaceuticals in the East European country, including novel anti-inflammatory, neuropsychiatric and oncology products.